Urine cytology: Is it still the gold standard for screening?

Urologic Clinics of North America

Volumn 27, Issue 1, 2000, Pages 25-37

  Brown, Felix M ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER CANCER; CANCER SCREENING; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SURGICAL TECHNIQUE; URINE CYTOLOGY;

EID: 0033982536     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70231-7     Document Type: Article

References (25)

1. R.A. Badalament D.K. Hermansen M. Kimmel The sensitivity of bladder wash flow cytometry, bladder wash cytology, and voided cytology in the detection of bladder carcinoma Cancer 60 1987 1423 1427
2. C.D. Belair T.R. Yeager P.M. Lopez Telomerase activity: A biomarker of cell proliferation, not malignant transformation J Urol 160 1998 620 621
3. R.M. DeMay Urine The Art & Science of Cytopathology 1996 ASCP Press Chicago
4. W.J. Ellis B.A. Blumenstein L.M. Ishak Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors Urology 50 1997 882 887
5. M. Gregoire Y. Fradet F. Meyer Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors J Urol 157 1997 1160 1664
6. H.B. Grossman New methods for detection of bladder cancer Semin Urol Oncol 16 1998 17 22
7. R.H. Hruban P. Van Der Riet S.E. Yener Brief report: Molecular biology and the early detection of carcinoma of the bladder—the case of Hubert H. Humphrey N Engl J Med 330 1994 1276 1278
8. V. Kannan S. Bose Low grade transitional cell carcinoma and instrument artifact: A challenge in urinary cytology Acta Cytol 37 1993 899 902
9. S.H. Kroft R. Oyasu Urinary bladder cancer: Mechanisms of development and progression Lab Invest 71 1994 158 174
10. S.H. Landis T. Murray S. Bolden Cancer statistics, 1998 CA Cancer J Clin 48 1998 6 29
11. H. Leyh R. Hall E. Mazeman Comparison of the Bard BTA test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder Urology 50 1997 49 53
12. T.S. Loy C.J. Alexander R.D. Calaluce Lewis X antigen immunostaining in the diagnosis of transitional cell carcinoma Mod Pathol 8 1995 587 590
13. W.M. Murphy I. Rivera-Ramirez C.A. Medina The bladder tumor antigen (BTA) test compared to voided urine cytology in the detection of bladder neoplasms J Urol 158 1997 2102 2106
14. W.M. Murphy M.S. Soloway A.F. Jukkola Urinary cytology and bladder cancer: The cellular features of transitional cell neoplasms Cancer 53 1984 1555 1565
15. G.N. Papanicolaou V.F. Marshall Urine sediment smears as a diagnostic procedure in cancers of the urinary tract Science 101 1945 519 520
16. D. Pode A. Shapiro M. Wald Noninvasive detection of bladder cancer with the BTA stat test J Urol 161 1999 443 446
17. S.S. Raab J.C. Lenel M.B. Cohen Low grade transitional cell carcinoma of the bladder: Cytologic diagnosis by key features as identified by logistic regression analysis Cancer 74 1994 1621 1626
18. S.S. Raab D.D. Slagel C.S. Jensen Transitional cell carcinoma: Cytologic criteria to improve diagnostic accuracy Mod Pathol 9 1996 225 232
19. S. Ramakumar J. Bhuiyan J.A. Besse Comparison of screening methods in the detection of bladder cancer J Urol 161 1999 388 394
20. A.A. Renshaw D. Nappi D.S. Weinberg Cytology of grade 1 papillary transitional cell carcinoma: A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine Acta Cytol 40 1996 676 682
21. E. Righi G. Rossi G. Ferrari Does p53 immunostaining improve diagnostic accuracy in urine cytology? Diagn Cytopathol 17 1997 436 439
22. B.S. Schmetter K.K. Habicht D.L. Lamm A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer J Urol 158 1997 801 805
23. D. Sidransky A. Von Eshenbach Y.C. Tsai Identification of p53 gene mutations in bladder cancers and urine samples Science 252 1991 706 709
24. M.S. Soloway Editorial: Do we have a prostate specific antigen for bladder cancer? J Urol 161 1999 447 448
25. E.M. Wojcik M.C. Miller G.J. O'Dowd Value of computer-assisted quantitative nuclear grading in differentiation of normal urothelial cells from low and high grade transitional cell carcinoma Anal Quant Cytol Histol 20 1998 69 76